Compile Data Set for Download or QSAR
Report error Found 546 Enz. Inhib. hit(s) with Target = 'Caspase-9'
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50140543(3-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylam...)
Affinity DataIC50: 5nMAssay Description:Compound was evaluated for its inhibitory activity against the Caspase-9 enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2012
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50223100(2-(2-((S)-2-(benzyloxycarbonyl)-3-methylbutanamido...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human caspase 9More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50153668(3-[(S)-2-(2,4-Dichloro-benzyloxycarbonylamino)-3-m...)
Affinity DataIC50: 9nMAssay Description:Inhibition concentration required against caspase-9More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM34671(1,3,6-Trimethyl-1H-pyrimido[5,4-e][1,2,4]triazine-...)
Affinity DataIC50: 25.6nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50161452(5-Fluoro-3-((S)-3-methyl-2-phenylcarbamoyloxy-buty...)
Affinity DataIC50: 30nMAssay Description:Inhibitory concentration against Caspase-9More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM572145(US11447497, Example 2)
Affinity DataIC50: 38nMAssay Description:Caspase-1 was diluted to 10 U/μl in assay buffer consisting of 50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% glycerol and 10 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM43224(SMR000278513 | MLS000717146 | 1-ethyl-6-methyl-3-[...)
Affinity DataIC50: 51.9nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM572147(US11447497, Example 4)
Affinity DataIC50: 107nMAssay Description:Caspase-1 was diluted to 10 U/μl in assay buffer consisting of 50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% glycerol and 10 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM10323(JMC522188 Compound 2 | IST-3 | CHEMBL439753 | 1-be...)
Affinity DataKi:  120nMAssay Description:The substrate peptides terminating in AMC/AFC are processed by caspases with or without inhibitors, and the accumulation of AMC/AFC was assessed with...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2006
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM572144(US11447497, Example 1)
Affinity DataIC50: 122nMAssay Description:Caspase-1 was diluted to 10 U/μl in assay buffer consisting of 50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% glycerol and 10 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM51771(1,6-dimethyl-3-pyridin-2-ylpyrimido[5,4-e][1,2,4]t...)
Affinity DataIC50: 145nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50145622((S)-3-{(S)-4-Methyl-2-[2-(naphthalen-1-ylamino)-ac...)
Affinity DataIC50: 160nMAssay Description:Binding affinity towards human Caspase-9More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM32061(SMR000061605 | cid_2997948 | 1,8-diamino-3,6-dipyr...)
Affinity DataIC50: 209nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50145661((S)-3-{(S)-4-Methyl-2-[(naphthalen-1-ylaminooxalyl...)
Affinity DataIC50: 230nMAssay Description:Binding affinity towards human Caspase-9More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50512892(CHEMBL4460352)
Affinity DataEC50:  240nMAssay Description:Inhibition of N-terminal CARD domain of caspase 9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM71274(SMR000472416 | 6-(3-ethanoylphenyl)-3-phenylazanyl...)
Affinity DataIC50: 289nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM13167((2S)-1-[(2S)-3,3-dimethyl-2-[(2S)-2-(methylamino)p...)
Affinity DataEC50:  290nMAssay Description:Inhibition of N-terminal CARD domain of caspase 9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50233673(cid_3718 | (+)-2-(4-(1-oxoisoindolin-2-yl)phenyl)p...)
Affinity DataIC50: 300nMpH: 7.4Assay Description:Experiments were performed in a 384-well format (Greiner no. 781207) as per the conditions noted here. Caspase-1: 2.5 nM enzyme, 6.5 mM WEHD substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/27/2017
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160798(US9045524, 65 | US10167313, Compound 65)
Affinity DataIC50: 300nMT: 2°CAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2016
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160798(US9045524, 65 | US10167313, Compound 65)
Affinity DataIC50: 300nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50512891(CHEMBL4459769)
Affinity DataEC50:  310nMAssay Description:Inhibition of N-terminal CARD domain of caspase 9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM83913(cid_4422714 | 4-chloro-3-nitro-N'-[1-oxo-3-(1,2,3,...)
Affinity DataIC50: 342nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM83973(MLS002153809 | SMR001233181 | cid_25102581 | CYANO...)
Affinity DataIC50: 437nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160781(US9045524, 48 | US10167313, Compound 48)
Affinity DataIC50: 500nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160792(US9045524, 59 | US10167313, Compound 59)
Affinity DataIC50: 500nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160792(US9045524, 59 | US10167313, Compound 59)
Affinity DataIC50: 500nMT: 2°CAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2016
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM41038(SMR000151472 | (NE)-N-[3-(2-methylanilino)-4-oxona...)
Affinity DataIC50: 548nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099737(CHEMBL417727 | cid_254021 | 2-Amino-phenanthrene-9...)
Affinity DataIC50: 643nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM40313(cid_9549141 | SMR000115581 | 3-phenyl-9,10-phenant...)
Affinity DataIC50: 685nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM41816(cid_9549688 | MLS000549894 | SMR000113727 | (NE)-N...)
Affinity DataIC50: 689nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM83912(MLS000590906 | 4-Nitro-benzoic acid N'-(3-1,2,...)
Affinity DataIC50: 728nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50240374(4-[1,1'-biphenyl-4-yl]-4-oxobutanoic acid | 3-(4-b...)
Affinity DataIC50: 760nMpH: 7.4Assay Description:Experiments were performed in a 384-well format (Greiner no. 781207) as per the conditions noted here. Caspase-1: 2.5 nM enzyme, 6.5 mM WEHD substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/27/2017
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50426562(CHEMBL2324339)
Affinity DataIC50: 800nMAssay Description:Inhibition of caspase-9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2013
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85511(Toradol | KETOROLAC | CAS_74103-07-4 | Ketorolac t...)
Affinity DataIC50: 850nMpH: 7.4Assay Description:Experiments were performed in a 384-well format (Greiner no. 781207) as per the conditions noted here. Caspase-1: 2.5 nM enzyme, 6.5 mM WEHD substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/27/2017
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM10315(5-{[(2S)-2-[(phenylamino)methyl]pyrrolidine-1-]sul...)
Affinity DataKi:  850nMAssay Description:The substrate peptides terminating in AMC/AFC are processed by caspases with or without inhibitors, and the accumulation of AMC/AFC was assessed with...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2006
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM70782(MLS000585839 | SMR000207620 | N-[(1Z)-3-[(4-methyl...)
Affinity DataIC50: 869nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM22857(cid_6763 | 9,10-dihydrophenanthrene-9,10-dione | P...)
Affinity DataIC50: 903nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM71432((NE)-N-[3-[(4-hydroxyphenyl)amino]-4-oxidanylidene...)
Affinity DataIC50: 937nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50426566(CHEMBL2324341)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of caspase-9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2013
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM572146(US11447497, Example 3)
Affinity DataIC50: 1.00E+3nMAssay Description:Caspase-1 was diluted to 10 U/μl in assay buffer consisting of 50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% glycerol and 10 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM71268(6-bromo-3-(2-methoxyanilino)-2H-isoquinolin-1-one ...)
Affinity DataIC50: 1.07E+3nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50426563(CHEMBL2323967)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of caspase-9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2013
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM10305((S)-5-[1-(2-Methoxymethyl)pyrrolidinylsulfonyl]isa...)
Affinity DataKi:  1.10E+3nMAssay Description:The substrate peptides terminating in AMC/AFC are processed by caspases with or without inhibitors, and the accumulation of AMC/AFC was assessed with...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2006
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM65983(cid_1266914 | 6-methyl-3-pyridin-4-yl-[1,2,4]triaz...)
Affinity DataIC50: 1.11E+3nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM34768(MLS000566872 | N6-[(4-methoxyphenyl)methylideneami...)
Affinity DataIC50: 1.16E+3nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM10318(5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}...)
Affinity DataKi:  1.20E+3nMAssay Description:The substrate peptides terminating in AMC/AFC are processed by caspases with or without inhibitors, and the accumulation of AMC/AFC was assessed with...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2006
Entry Details Article
PubMed
TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160781(US9045524, 48 | US10167313, Compound 48)
Affinity DataIC50: 1.20E+3nMT: 2°CAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2016
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160781(US9045524, 48 | US10167313, Compound 48)
Affinity DataIC50: 1.20E+3nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM160781(US9045524, 48 | US10167313, Compound 48)
Affinity DataIC50: 1.20E+3nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
US Patent

TargetCaspase-9(Human)
Maxim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM40316(cid_1736381 | ethyl 8-bromo-2,3-dimethyl-4,5-dioxo...)
Affinity DataIC50: 1.37E+3nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBIMR, San Diego, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2012
Entry Details
PCBioAssay
Displayed 1 to 50 (of 546 total ) | Next | Last >>
Jump to: